Developing Chemical Probes to Decipher Gankyrin Biology

Information

  • Research Project
  • 10088655
  • ApplicationId
    10088655
  • Core Project Number
    SC2GM139672
  • Full Project Number
    1SC2GM139672-01
  • Serial Number
    139672
  • FOA Number
    PAR-20-040
  • Sub Project Id
  • Project Start Date
    3/1/2021 - 3 years ago
  • Project End Date
    2/29/2024 - 7 months ago
  • Program Officer Name
    BERNAL, FEDERICO
  • Budget Start Date
    3/1/2021 - 3 years ago
  • Budget End Date
    2/28/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    2/26/2021 - 3 years ago

Developing Chemical Probes to Decipher Gankyrin Biology

Abstract. Gankyrin is an oncoprotein overexpressed in numerous cancer types and appears to play key roles in regulating cell proliferation, cell migration and epithelial-mesenchymal transition. These roles are primarily due to gankyrin?s numerous protein-protein interactions. The importance of these protein-protein interactions has been demonstrated by either decreasing gankyrin expression levels or directly disrupting its protein-protein interactions, which has resulted in decreased cell proliferation, cell migration and epithelial-mesenchymal transition, as well as disease severity in animal models of numerous cancer types. Therefore, gankyrin has been identified as an intriguing protein in multiple cancer types. However, much of how gankyrin regulates cell proliferation, cell migration and epithelial-mesenchymal transition is poorly understood. The overall goal of this proposal is to further develop our gankyrin-targeting probes which can be utilized to decipher much of gankyrin?s biological role in regulating cancer cell proliferation, migration and epithelial-mesenchymal transition. Furthermore, these probes will help in validating gankyrin as a therapeutic target due to its diverse roles in multiple cancer types. In order to achieve this goal, we are seeking to improve the ability of the cjoc42 scaffold to bind gankyrin and increase efficacy in specific cell-based assays. This proposal will also seek to provide preliminary data about gankyrin?s role in cancer biology, but the primary focus will be to develop and validate our probes as useful in future experiments. Ultimately, this proposal will provide the chemical probes required to fully understand gankyrin?s biological roles which will directly impact therapeutic advancements in multiple cancer types.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    SC2
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
    100000
  • Indirect Cost Amount
    64000
  • Total Cost
    164000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF PHARMACY
  • Funding ICs
    NIGMS:164000\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ST. JOHN'S UNIVERSITY
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    073134744
  • Organization City
    QUEENS
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    114399000
  • Organization District
    UNITED STATES